Valeant Gets Funding for Bausch Deal; RCN Cable Unit Refinances

Valeant Pharmaceuticals International Inc. obtained as much as $7.2 billion of debt financing for its purchase of Bausch & Lomb Holdings Inc., while RCN Corp.’s Yankee cable unit was among companies asking lenders in the loan market to lower their borrowing costs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.